CardieX (ASX:CDX) Change In Inventory : A$0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is CardieX Change In Inventory?

CardieX's change in inventory for the quarter that ended in Dec. 2023 was A$0.00 Mil. It means CardieX's inventory stayed the same from Jun. 2023 to Dec. 2023 .

CardieX's change in inventory for the fiscal year that ended in Jun. 2023 was A$0.00 Mil. It means CardieX's inventory stayed the same from Jun. 2022 to Jun. 2023 .

CardieX's Total Inventories for the quarter that ended in Dec. 2023 was A$2.50 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. CardieX's Days Inventory for the quarter that ended in Dec. 2023 was 1,102.96.

Inventory Turnover measures how fast the company turns over its inventory within a year. CardieX's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.17.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. CardieX's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.22.

CardieX Change In Inventory Historical Data

The historical data trend for CardieX's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardieX Change In Inventory Chart

CardieX Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Change In Inventory

Get a 7-Day Free Trial

CardieX Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

CardieX Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

CardieX (ASX:CDX) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

CardieX's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	2.079	/	0.344	*	365 / 2
	=	1,102.96

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

CardieX's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.344	/	2.079
	=	0.17

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

CardieX's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	2.079	/	9.471
	=	0.22

CardieX Change In Inventory Related Terms

Thank you for viewing the detailed overview of CardieX's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

CardieX (ASX:CDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CardieX Ltd (ASX:CDX) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

55 Lime Street, Suite 301, Level 3, Sydney, NSW, AUS, 2000

Website

https://www.cardiex.com

CardieX Ltd is a global health technology company, developing solutions for health disorders. The AtCor Medical division develops medical devices for measuring arterial stiffness and central blood pressure waveforms based on its patented SphygmoCor technology. It also develops and licenses its Arty platform consisting of physiological and health analytics for wearable devices. It reports in a single segment being sales of cardiovascular devices and services to hospitals, clinics, research institutions, and pharmaceutical companies. The company has three reportable segments by geographic area namely the Americas includes, global pharmaceutical trials business, Europe includes, the Middle East and Africa and the Asia Pacific includes, Asia and Australia/New Zealand.

CardieX (ASX:CDX) Headlines

No Headlines